In 2001, Glenmark Pharmaceuticals established its API business. The first product registered with USFDA in 2003. The Company acquired Glaxo SmithKlines (GSK) API manufacturing plant in Ankleshwar ...

J B Chemicals & Pharmaceuticals (JBC ... The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman. The bulk drug plant at Panoli and formulation plant at Daman became ...

Glenmark Pharmaceuticals Ltd share price was down by -1.12% from the previous closing price of ₹1,453.20. Who are peers of Glenmark Pharmaceuticals Ltd? The peers of Glenmark Pharmaceuticals Ltd ...

Indian stock markets opened higher on Wednesday, driven by fresh foreign fund inflows and a positive trend in US markets. Sensex gained 151.6 points, Nifty rose 68.05 points. Feb 05, 2025 09:55 Ola ...

New Delhi: Drug major Glenmark Pharmaceutical has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to import and market ...

Revenue 3,433.80 3,244.19 3,062.95 2,506.70 ...

Malpani Pipes IPO: Ahead of listing, Malpani Pipes And Fittings' shares traded at a Rs 10-11 GMP on Friday, an 11% premium over the Rs 90 IPO price band. Net IPO proceeds will fund capital expenditure ...

President Trump on Friday vowed to impose sweeping tariffs on semiconductor chips, pharmaceuticals, steel and aluminum and oil and gas. “We’ll be doing pharmaceuticals. Importantly in drugs ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

India has 29 states with at least 720 districts comprising of approximately 6 lakh villages, and over 8200 cities and towns. Indian postal department has allotted a unique postal code of pin code ...

The pharmaceutical industry is at a pivotal moment. Artificial intelligence (AI) is shifting from improving processes to reshaping disease treatment and care delivery. Early adopters are seeing ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.